We used a transgenic murine model to demonstrate a pro-fibrotic role for CSF1 and AKT in the lungs, and believe that these observations may be applicable to clinical lung disease, as we showed overexpressing AKT predisposes lungs to fibrosis in the presence of bleomycin. The gene discussed is CSF1; the disease is lung disorder.